The Fourth Left Atrial Appendage Occlusion Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4000 participants.
Also called NCT05963698
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 4,000 participants
- Sponsor
- Registry
-
NCT05963698
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT05963698. Randomized; single masking; primary purpose treatment. Start 2023-11-30 (actual); primary completion 2029-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Fourth Left Atrial Appendage Occlusion Study
- Acronym
- LAAOS-4
- Condition
- Atrial Fibrillation
- Condition
- Stroke, Ischemic
- Condition
- Systemic Embolism
- Intervention (Device)
- WATCHMAN device
- Lead sponsor
- Hamilton Health Sciences Corporation
- Collaborator
- McMaster University
- Collaborator
- Population Health Research Institute
- Collaborator
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct05963698- Content hash
2dcf7cf31fbf6e52b5148e6568ff5a6842194a4eb5ee9f07b8612241abe391e0